Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder.

Murray GK, Knolle F, Ersche KD, Craig KJ, Abbott S, Shabbir SS, Fineberg NA, Suckling J, Sahakian BJ, Bullmore ET, Robbins TW.

Psychopharmacology (Berl). 2019 Jun 14. doi: 10.1007/s00213-019-05292-2. [Epub ahead of print]

PMID:
31201476
2.

Neural circuitry and mechanisms of waiting impulsivity: relevance to addiction.

Dalley JW, Ersche KD.

Philos Trans R Soc Lond B Biol Sci. 2019 Feb 18;374(1766):20180145. doi: 10.1098/rstb.2018.0145.

PMID:
30966923
3.

Goal-Directed and Habitual Control in Smokers.

Luijten M, Gillan CM, De Wit S, Franken IHA, Robbins TW, Ersche KD.

Nicotine Tob Res. 2019 Feb 15. pii: ntz001. doi: 10.1093/ntr/ntz001. [Epub ahead of print]

PMID:
30768206
4.

Effects of familial risk and stimulant drug use on the anticipation of monetary reward: an fMRI study.

Just AL, Meng C, Smith DG, Bullmore ET, Robbins TW, Ersche KD.

Transl Psychiatry. 2019 Feb 4;9(1):65. doi: 10.1038/s41398-019-0399-4.

5.

BMI-related cortical morphometry changes are associated with altered white matter structure.

Medic N, Kochunov P, Ziauddeen H, Ersche KD, Nathan PJ, Ronan L, Fletcher PC.

Int J Obes (Lond). 2019 Mar;43(3):523-532. doi: 10.1038/s41366-018-0269-9. Epub 2018 Dec 19.

PMID:
30568264
6.

Naltrexone differentially modulates the neural correlates of motor impulse control in abstinent alcohol-dependent and polysubstance-dependent individuals.

Nestor LJ, Paterson LM, Murphy A, McGonigle J, Orban C, Reed L, Taylor E, Flechais R, Smith D, Bullmore ET, Ersche KD, Suckling J, Elliott R, Deakin B, Rabiner I, Lingford Hughes A, Sahakian BJ, Robbins TW, Nutt DJ; ICCAM Consortium.

Eur J Neurosci. 2018 Nov 6. doi: 10.1111/ejn.14262. [Epub ahead of print]

PMID:
30402987
7.

Creature of Habit: A self-report measure of habitual routines and automatic tendencies in everyday life.

Ersche KD, Lim TV, Ward LHE, Robbins TW, Stochl J.

Pers Individ Dif. 2017 Oct 1;116:73-85. doi: 10.1016/j.paid.2017.04.024.

8.

Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence.

Murphy A, Nestor LJ, McGonigle J, Paterson L, Boyapati V, Ersche KD, Flechais R, Kuchibatla S, Metastasio A, Orban C, Passetti F, Reed L, Smith D, Suckling J, Taylor E, Robbins TW, Lingford-Hughes A, Nutt DJ, Deakin JFW, Elliott R; ICCAM Platform.

Neuropsychopharmacology. 2017 Aug;42(9):1925-1926. doi: 10.1038/npp.2017.99.

9.

Atomoxetine effects on attentional bias to drug-related cues in cocaine dependent individuals.

Passamonti L, Luijten M, Ziauddeen H, Coyle-Gilchrist ITS, Rittman T, Brain SAE, Regenthal R, Franken IHA, Sahakian BJ, Bullmore ET, Robbins TW, Ersche KD.

Psychopharmacology (Berl). 2017 Aug;234(15):2289-2297. doi: 10.1007/s00213-017-4643-4. Epub 2017 May 27.

10.

Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence.

Murphy A, Nestor LJ, McGonigle J, Paterson L, Boyapati V, Ersche KD, Flechais R, Kuchibatla S, Metastasio A, Orban C, Passetti F, Reed L, Smith D, Suckling J, Taylor E, Robbins TW, Lingford-Hughes A, Nutt DJ, Deakin JF, Elliott R; ICCAM Platform.

Neuropsychopharmacology. 2017 Jun;42(7):1559. doi: 10.1038/npp.2017.47. No abstract available.

11.

Effects of naltrexone are influenced by childhood adversity during negative emotional processing in addiction recovery.

Savulich G, Riccelli R, Passamonti L, Correia M, Deakin JF, Elliott R, Flechais RS, Lingford-Hughes AR, McGonigle J, Murphy A, Nutt DJ, Orban C, Paterson LM, Reed LJ, Smith DG, Suckling J, Tait R, Taylor EM, Sahakian BJ, Robbins TW, Ersche KD.

Transl Psychiatry. 2017 Mar 7;7(3):e1054. doi: 10.1038/tp.2017.34.

12.

Naltrexone ameliorates functional network abnormalities in alcohol-dependent individuals.

Morris LS, Baek K, Tait R, Elliott R, Ersche KD, Flechais R, McGonigle J, Murphy A, Nestor LJ, Orban C, Passetti F, Paterson LM, Rabiner I, Reed L, Smith D, Suckling J, Taylor EM, Bullmore ET, Lingford-Hughes AR, Deakin B, Nutt DJ, Sahakian BJ, Robbins TW, Voon V; ICCAM Consortium.

Addict Biol. 2018 Jan;23(1):425-436. doi: 10.1111/adb.12503. Epub 2017 Feb 28.

13.

Disrupted iron regulation in the brain and periphery in cocaine addiction.

Ersche KD, Acosta-Cabronero J, Jones PS, Ziauddeen H, van Swelm RP, Laarakkers CM, Raha-Chowdhury R, Williams GB.

Transl Psychiatry. 2017 Feb 21;7(2):e1040. doi: 10.1038/tp.2016.271.

14.

Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence.

Murphy A, Nestor LJ, McGonigle J, Paterson L, Boyapati V, Ersche KD, Flechais R, Kuchibatla S, Metastasio A, Orban C, Passetti F, Reed L, Smith D, Suckling J, Taylor E, Robbins TW, Lingford-Hughes A, Nutt DJ, Deakin JF, Elliott R.

Neuropsychopharmacology. 2017 Apr;42(5):1049-1057. doi: 10.1038/npp.2016.289. Epub 2017 Jan 2. Erratum in: Neuropsychopharmacology. 2017 Aug;42(9):1925-1926. Neuropsychopharmacology. 2017 Jun;42(7):1559.

15.

The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI description.

McGonigle J, Murphy A, Paterson LM, Reed LJ, Nestor L, Nash J, Elliott R, Ersche KD, Flechais RS, Newbould R, Orban C, Smith DG, Taylor EM, Waldman AD, Robbins TW, Deakin JW, Nutt DJ, Lingford-Hughes AR, Suckling J; ICCAM Platform.

J Psychopharmacol. 2017 Jan;31(1):3-16. doi: 10.1177/0269881116668592. Epub 2016 Oct 4.

16.

Acute naltrexone does not remediate fronto-striatal disturbances in alcoholic and alcoholic polysubstance-dependent populations during a monetary incentive delay task.

Nestor LJ, Murphy A, McGonigle J, Orban C, Reed L, Taylor E, Flechais R, Paterson LM, Smith D, Bullmore ET, Ersche KD, Suckling J, Tait R, Elliott R, Deakin B, Rabiner I, Lingford-Hughes A, Nutt DJ, Sahakian B, Robbins TW; ICCAM Consortium.

Addict Biol. 2017 Nov;22(6):1576-1589. doi: 10.1111/adb.12444. Epub 2016 Sep 6.

17.

Carrots and sticks fail to change behavior in cocaine addiction.

Ersche KD, Gillan CM, Jones PS, Williams GB, Ward LH, Luijten M, de Wit S, Sahakian BJ, Bullmore ET, Robbins TW.

Science. 2016 Jun 17;352(6292):1468-71. doi: 10.1126/science.aaf3700.

18.

Increased body mass index is associated with specific regional alterations in brain structure.

Medic N, Ziauddeen H, Ersche KD, Farooqi IS, Bullmore ET, Nathan PJ, Ronan L, Fletcher PC.

Int J Obes (Lond). 2016 Jul;40(7):1177-82. doi: 10.1038/ijo.2016.42. Epub 2016 Mar 22.

19.

Impulsivity in abstinent alcohol and polydrug dependence: a multidimensional approach.

Taylor EM, Murphy A, Boyapati V, Ersche KD, Flechais R, Kuchibatla S, McGonigle J, Metastasio A, Nestor L, Orban C, Passetti F, Paterson L, Smith D, Suckling J, Tait R, Lingford-Hughes AR, Robbins TW, Nutt DJ, Deakin JF, Elliott R; ICCAM Platform.

Psychopharmacology (Berl). 2016 Apr;233(8):1487-99. doi: 10.1007/s00213-016-4245-6. Epub 2016 Feb 25.

20.

The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description.

Paterson LM, Flechais RS, Murphy A, Reed LJ, Abbott S, Boyapati V, Elliott R, Erritzoe D, Ersche KD, Faluyi Y, Faravelli L, Fernandez-Egea E, Kalk NJ, Kuchibatla SS, McGonigle J, Metastasio A, Mick I, Nestor L, Orban C, Passetti F, Rabiner EA, Smith DG, Suckling J, Tait R, Taylor EM, Waldman AD, Robbins TW, Deakin JF, Nutt DJ, Lingford-Hughes AR; ICCAM Platform.

J Psychopharmacol. 2015 Sep;29(9):943-60. doi: 10.1177/0269881115596155. Epub 2015 Aug 5.

21.

Take it or leave it: prefrontal control in recreational cocaine users.

Morein-Zamir S, Simon Jones P, Bullmore ET, Robbins TW, Ersche KD.

Transl Psychiatry. 2015 Jun 16;5:e582. doi: 10.1038/tp.2015.80.

22.

In the face of threat: neural and endocrine correlates of impaired facial emotion recognition in cocaine dependence.

Ersche KD, Hagan CC, Smith DG, Jones PS, Calder AJ, Williams GB.

Transl Psychiatry. 2015 May 26;5:e570. doi: 10.1038/tp.2015.58.

23.

Cocaine's appetite for fat and the consequences on body weight.

Billing L, Ersche KD.

Am J Drug Alcohol Abuse. 2015 Mar;41(2):115-8. doi: 10.3109/00952990.2014.966196. Epub 2014 Oct 16. Review.

PMID:
25321424
24.

Paying attention to biased attention in drug addiction.

Ersche KD.

CNS Spectr. 2014 Jun;19(3):213-4. doi: 10.1017/S1092852914000170. No abstract available.

PMID:
24901505
25.

A wavelet method for modeling and despiking motion artifacts from resting-state fMRI time series.

Patel AX, Kundu P, Rubinov M, Jones PS, Vértes PE, Ersche KD, Suckling J, Bullmore ET.

Neuroimage. 2014 Jul 15;95:287-304. doi: 10.1016/j.neuroimage.2014.03.012. Epub 2014 Mar 21.

26.

Using a drug-word Stroop task to differentiate recreational from dependent drug use.

Smith DG, Ersche KD.

CNS Spectr. 2014 Jun;19(3):247-55. doi: 10.1017/S1092852914000133. Epub 2014 Mar 14. Review.

PMID:
24625759
27.

Signing below the dotted line: signature position as a marker of vulnerability for visuospatial processing difficulties.

Whitelock CF, Agyepong HN, Patterson K, Ersche KD.

Neurocase. 2015 Feb;21(1):67-72. doi: 10.1080/13554794.2013.860178. Epub 2013 Dec 7.

28.

Aberrant disgust responses and immune reactivity in cocaine-dependent men.

Ersche KD, Hagan CC, Smith DG, Abbott S, Jones PS, Apergis-Schoute AM, Döffinger R.

Biol Psychiatry. 2014 Jan 15;75(2):140-7. doi: 10.1016/j.biopsych.2013.08.004. Epub 2013 Oct 3.

29.

Overlapping decline in orbitofrontal gray matter volume related to cocaine use and body mass index.

Smith DG, Jones PS, Williams GB, Bullmore ET, Robbins TW, Ersche KD.

Addict Biol. 2015 Jan;20(1):194-6. doi: 10.1111/adb.12081. Epub 2013 Aug 8.

PMID:
23927455
30.

The skinny on cocaine: insights into eating behavior and body weight in cocaine-dependent men.

Ersche KD, Stochl J, Woodward JM, Fletcher PC.

Appetite. 2013 Dec;71:75-80. doi: 10.1016/j.appet.2013.07.011. Epub 2013 Aug 3.

31.

Enhanced orbitofrontal cortex function and lack of attentional bias to cocaine cues in recreational stimulant users.

Smith DG, Simon Jones P, Bullmore ET, Robbins TW, Ersche KD.

Biol Psychiatry. 2014 Jan 15;75(2):124-31. doi: 10.1016/j.biopsych.2013.05.019. Epub 2013 Jun 27.

PMID:
23809860
32.

Cognitive control dysfunction and abnormal frontal cortex activation in stimulant drug users and their biological siblings.

Smith DG, Jones PS, Bullmore ET, Robbins TW, Ersche KD.

Transl Psychiatry. 2013 May 14;3:e257. doi: 10.1038/tp.2013.32.

33.

Prefrontal hypoactivity associated with impaired inhibition in stimulant-dependent individuals but evidence for hyperactivation in their unaffected siblings.

Morein-Zamir S, Simon Jones P, Bullmore ET, Robbins TW, Ersche KD.

Neuropsychopharmacology. 2013 Sep;38(10):1945-53. doi: 10.1038/npp.2013.90. Epub 2013 Apr 22.

34.

Meta-analysis of structural brain abnormalities associated with stimulant drug dependence and neuroimaging of addiction vulnerability and resilience.

Ersche KD, Williams GB, Robbins TW, Bullmore ET.

Curr Opin Neurobiol. 2013 Aug;23(4):615-24. doi: 10.1016/j.conb.2013.02.017. Epub 2013 Mar 20. Review.

35.

Who Do You Think Is in Control in Addiction? A Pilot Study on Drug-related Locus of Control Beliefs.

Ersche KD, Turton AJ, Croudace T, Stochl J.

Addict Disord Their Treat. 2012 Dec;11(4):173-223.

36.

Distinctive personality traits and neural correlates associated with stimulant drug use versus familial risk of stimulant dependence.

Ersche KD, Jones PS, Williams GB, Smith DG, Bullmore ET, Robbins TW.

Biol Psychiatry. 2013 Jul 15;74(2):137-44. doi: 10.1016/j.biopsych.2012.11.016. Epub 2012 Dec 27.

37.

Neurobiological correlates of the familial risk for stimulant drug dependence.

Ersche KD.

Neuropsychopharmacology. 2013 Jan;38(1):238-9. doi: 10.1038/npp.2012.183. Review. No abstract available.

38.

Cognitive dysfunction and anxious-impulsive personality traits are endophenotypes for drug dependence.

Ersche KD, Turton AJ, Chamberlain SR, Müller U, Bullmore ET, Robbins TW.

Am J Psychiatry. 2012 Sep;169(9):926-36. doi: 10.1176/appi.ajp.2012.11091421.

39.

Cocaine dependence: a fast-track for brain ageing?

Ersche KD, Jones PS, Williams GB, Robbins TW, Bullmore ET.

Mol Psychiatry. 2013 Feb;18(2):134-5. doi: 10.1038/mp.2012.31. Epub 2012 Apr 24. No abstract available.

40.

Abnormal brain structure implicated in stimulant drug addiction.

Ersche KD, Jones PS, Williams GB, Turton AJ, Robbins TW, Bullmore ET.

Science. 2012 Feb 3;335(6068):601-4. doi: 10.1126/science.1214463.

41.

Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry.

Robbins TW, Gillan CM, Smith DG, de Wit S, Ersche KD.

Trends Cogn Sci. 2012 Jan;16(1):81-91. doi: 10.1016/j.tics.2011.11.009. Epub 2011 Dec 10. Review.

PMID:
22155014
42.

Response perseveration in stimulant dependence is associated with striatal dysfunction and can be ameliorated by a D(2/3) receptor agonist.

Ersche KD, Roiser JP, Abbott S, Craig KJ, Müller U, Suckling J, Ooi C, Shabbir SS, Clark L, Sahakian BJ, Fineberg NA, Merlo-Pich EV, Robbins TW, Bullmore ET.

Biol Psychiatry. 2011 Oct 15;70(8):754-62. doi: 10.1016/j.biopsych.2011.06.033.

PMID:
21967987
43.

Brain functional connectivity in stimulant drug dependence and obsessive-compulsive disorder.

Meunier D, Ersche KD, Craig KJ, Fornito A, Merlo-Pich E, Fineberg NA, Shabbir SS, Robbins TW, Bullmore ET.

Neuroimage. 2012 Jan 16;59(2):1461-8. doi: 10.1016/j.neuroimage.2011.08.003. Epub 2011 Aug 16.

PMID:
21871569
44.

Amisulpride-induced acute akathisia in OCD: an example of dysfunctional dopamine-serotonin interactions?

Ersche KD, Cumming P, Craig KJ, Müller U, Fineberg NA, Bullmore ET, Robbins TW.

J Psychopharmacol. 2012 Jun;26(6):887-90. doi: 10.1177/0269881111405363. Epub 2011 Jul 11.

45.

Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence.

Ersche KD, Barnes A, Jones PS, Morein-Zamir S, Robbins TW, Bullmore ET.

Brain. 2011 Jul;134(Pt 7):2013-24. doi: 10.1093/brain/awr138. Epub 2011 Jun 20.

46.

Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment.

Ersche KD, Roiser JP, Lucas M, Domenici E, Robbins TW, Bullmore ET.

Psychopharmacology (Berl). 2011 Apr;214(4):779-89. doi: 10.1007/s00213-010-2087-1. Epub 2010 Nov 19.

47.

Differences in self-reported decision-making styles in stimulant-dependent and opiate-dependent individuals.

Gorodetzky H, Sahakian BJ, Robbins TW, Ersche KD.

Psychiatry Res. 2011 Apr 30;186(2-3):437-40. doi: 10.1016/j.psychres.2010.07.024. Epub 2010 Aug 24. Erratum in: Psychiatry Res. 2011 Jun 30;188(1):178.

48.

Drug addiction endophenotypes: impulsive versus sensation-seeking personality traits.

Ersche KD, Turton AJ, Pradhan S, Bullmore ET, Robbins TW.

Biol Psychiatry. 2010 Oct 15;68(8):770-3. doi: 10.1016/j.biopsych.2010.06.015. Epub 2010 Aug 1.

49.

Impaired visuospatial associative memory and attention in obsessive compulsive disorder but no evidence for differential dopaminergic modulation.

Morein-Zamir S, Craig KJ, Ersche KD, Abbott S, Muller U, Fineberg NA, Bullmore ET, Sahakian BJ, Robbins TW.

Psychopharmacology (Berl). 2010 Oct;212(3):357-67. doi: 10.1007/s00213-010-1963-z. Epub 2010 Jul 27.

PMID:
20661550
50.

Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence.

Ersche KD, Bullmore ET, Craig KJ, Shabbir SS, Abbott S, Müller U, Ooi C, Suckling J, Barnes A, Sahakian BJ, Merlo-Pich EV, Robbins TW.

Arch Gen Psychiatry. 2010 Jun;67(6):632-44. doi: 10.1001/archgenpsychiatry.2010.60.

Supplemental Content

Loading ...
Support Center